1999
DOI: 10.1002/(sici)1096-8628(19990903)86:1<71::aid-ajmg14>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

Methylenetetrahydrofolate reductase thermolabile variant and oral clefts

Abstract: Folic acid can prevent neural tube defects; in some cases the mechanism is probably a correction of a metabolic defect caused by thermolabile methylenetetrahydrofolate reductase (MTHFR) found in increased frequency in cases. It is less clear whether folic acid can prevent oral clefts, in part because it is not known whether thermolabile MTHFR is more common in those with oral clefts. This study examined the prevalence of the mutation (677 C-->T) that causes thermolabile MTHFR in subjects with oral clefts from … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0
2

Year Published

1999
1999
2008
2008

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 110 publications
(20 citation statements)
references
References 17 publications
0
18
0
2
Order By: Relevance
“…Some studies of MTHFR 677 C→T have shown no association with CLP in either cases or mothers while others have reported associations in mothers, or in mothers who did not use folic acid periconceptionally (Jugessur et al, 2003; Gaspar et al, 1999; Blanton et al, 2002; Martinelli et al, 2001; Prescott et al, 2002; Shotelersuk et al, 2003; Shaw et al, 1998; van Rooij et al, 2003; Mills et al, 1999). One recent study (Chevrier et al, 2007) found that the TT genotype was significantly protective in their case control analysis, although the authors noted that the sample size was small and that the TT rate in controls was higher than expected.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Some studies of MTHFR 677 C→T have shown no association with CLP in either cases or mothers while others have reported associations in mothers, or in mothers who did not use folic acid periconceptionally (Jugessur et al, 2003; Gaspar et al, 1999; Blanton et al, 2002; Martinelli et al, 2001; Prescott et al, 2002; Shotelersuk et al, 2003; Shaw et al, 1998; van Rooij et al, 2003; Mills et al, 1999). One recent study (Chevrier et al, 2007) found that the TT genotype was significantly protective in their case control analysis, although the authors noted that the sample size was small and that the TT rate in controls was higher than expected.…”
Section: Discussionmentioning
confidence: 99%
“…The majority (80%) of Irish patients with cleft lip and palate are treated through the Centre. Subjects were also recruited from the membership of the Cleft Lip and Palate Association of Ireland as previously described (Mills et al, 1999). Cleft subjects or their parents were either interviewed or completed the interview questionnaire themselves and, when necessary, had an interviewer review their answers with them in order to collect data on socio-demographic variables, obstetrical history, family history, and relevant data on the affected pregnancy including medication use, folic acid exposure, alcohol, and smoking.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Associations have only been found in small studies that lack corroboration when larger groups are tested. [7][8][9][10] We have established MTHFR genotypes in 243 CLP affected subjects and their parents (226 mothers and 210 fathers) in order to determine if genetic susceptibility to folate deficiency may play a role in the development of oral clefts. Families were recruited from the white UK population via the Great Ormond Street Children's Hospital, London.…”
mentioning
confidence: 99%
“…In contrast, Ray et al (2003) reported no change in the risk for orofacial clefts preand post-folic acid fortification of the food supply in Canada. There is epidemiological evidence that the offspring of mothers' homozygous for the 677C >T MTHFR variant may be at increased risk of orofacial clefts, especially among women with low folate intake in some (Mills et al, 1999; van Rooij et al, 2003), but not all studies (Jugessur et al, 2003; Shaw et al, 1998)…”
Section: Folate During the Periconceptional Periodmentioning
confidence: 99%